July 24, 2017 / 11:43 AM / in 5 months

BRIEF-ESSA Pharma provides further update on proposed equity offering

July 24 (Reuters) - Essa Pharma Inc

* Says additional data is currently being received from higher dose cohorts in Phase 1 clinical trial of EPI-506

* Says intends to delay an offering until after that data can be announced from ongoing highest dose cohorts

* Says it will provide further updates as they become available Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below